Acelyrin, Inc.
SLRN
$2.69
-$0.06-2.18%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -37.94% | 31.40% | 160.09% | 291.31% | 587.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -53.47% | 117.88% | 97.66% | 380.07% | 513.30% |
| Operating Income | 53.47% | -117.88% | -97.66% | -380.07% | -513.30% |
| Income Before Tax | 42.16% | -229.01% | 80.18% | -380.70% | -482.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 42.16% | -229.01% | 80.18% | -380.70% | -482.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.16% | -229.01% | 80.18% | -380.70% | -482.67% |
| EBIT | 53.47% | -117.88% | -97.66% | -380.07% | -513.30% |
| EBITDA | 53.56% | -117.67% | -- | -- | -- |
| EPS Basic | 43.88% | -116.38% | 95.85% | 90.30% | 89.39% |
| Normalized Basic EPS | 56.37% | -116.35% | 61.93% | 89.28% | 89.39% |
| EPS Diluted | 43.88% | -116.38% | 95.85% | 90.30% | 89.39% |
| Normalized Diluted EPS | 56.37% | -116.35% | 61.93% | 89.28% | 89.39% |
| Average Basic Shares Outstanding | 3.06% | 52.06% | 377.81% | 4,854.76% | 5,390.72% |
| Average Diluted Shares Outstanding | 3.06% | 52.06% | 377.81% | 4,854.76% | 5,390.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
